Previous 10 | Next 10 |
GERMANTOWN, Md., Nov. 15, 2021 (GLOBE NEWSWIRE) -- Orgenesis Inc . (NASDAQ: ORGS) (“Orgenesis” or the “Company”), a global biotech company working to unlock the full potential of cell and gene therapies, has entered into a collaboration agreement (...
Orgenesis (NASDAQ:ORGS): Q3 GAAP EPS of $0.42 beats by $0.45. Revenue of $8.68M (+401.7% Y/Y) misses by $0.32M. Press Release For further details see: Orgenesis EPS beats by $0.45, misses on revenue
GERMANTOWN, Md., Nov. 04, 2021 (GLOBE NEWSWIRE) -- Orgenesis Inc . (NASDAQ: ORGS) (“Orgenesis” or the “Company”), a global biotech company working to unlock the full potential of cell and gene therapies, today reported financial results for the th...
GERMANTOWN, Md., Nov. 02, 2021 (GLOBE NEWSWIRE) -- Orgenesis Inc . (NASDAQ: ORGS) (“Orgenesis” or the “Company”), a global biotech company working to unlock the full potential of cell and gene therapies, today announced that it plans to host a co...
The following slide deck was published by Orgenesis Inc. in conjunction with this event. For further details see: Orgenesis (ORGS) Investor Presentation - Slideshow
Goal to accelerate development, QC testing and manufacturing of Orgenesis’ cell and gene therapy platform New assays being developed to potentially enhance the potency of cell and gene therapies for use within POCare platform Plan to develop companion diagnostic...
LOS ANGELES, CA / ACCESSWIRE / August 16, 2021 / The SNN Network Summer Virtual Event will take place on August 17-19, 2021, where 60 SmallCap, MicroCap and NanoCap public and private companies will be presenting via virtual webcast to a global investor audience. The SNN Network Summer Virt...
GERMANTOWN, MD / ACCESSWIRE / August 12, 2021 / Orgenesis Inc. (NASDAQ:ORGS), a global biotech company working to unlock the full potential of cell and gene therapies, today announced that it will be presenting at the SNN Network Summer Virtual Event 2021 on Thursday, August 19 at 8:00 am ET...
Orgenesis (NASDAQ:ORGS) perks up 7.8% premarket after reporting financial results for Q2 ended June 30, 2021. Q2 Revenue surged more than 500% over prior year to $10.5M, ahead of analysts expectation of $3.3M. The increase in revenue is attributable to technology transfer, setup, sc...
Orgenesis (NASDAQ:ORGS): Q2 GAAP EPS of -$0.11 beats by $0.12. Revenue of $10.54M (+502.3% Y/Y) beats by $7.24M. Shares +3.73% PM. Press Release For further details see: Orgenesis EPS beats by $0.12, beats on revenue
News, Short Squeeze, Breakout and More Instantly...
A look at the top 10 most actives in the United States NVIDIA Corporation (NVDA) fell 2.7% to $127.255 on volume of 88,797,787 shares Ascent Solar Technologies Inc (ASTI) rose 9.6% to $0.1183 on volume of 88,651,038 shares Crown Electrokinetics Corp. (CRKN) fell 19.0% to $0.040499 on volu...